Home / Remifentanil / Australia
AU ATC N01AH06 · updated 2 Nov 2026
Remifentanil shortage in Australia
Is there a Remifentanil shortage in Australia?
Yes. As of 2 Nov 2026, 2 Remifentanil products are reported short in Australia, the first since 16 Oct 2026. The company estimate for the return is 16 Jan 2027 (latest 20 Jan 2027). Main reason: not stated.
Also short in United States, Canada, Czechia, Norway. All countries.
Affected products in Australia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AU | Remifentanil-AFT, remifentanil (as hydrochloride) 1 mg, powder for injection, glass vial | 16 Oct 2026 | 16 Jan 2027 | Not stated | |
| AU | REMIFENTANIL VIATRIS 1mg remifentanil (as hydrochloride) powder for injection vial anticipated | 11 Dec 2026 | 20 Jan 2027 | Not stated |
Source
Therapeutic Goods Administration (TGA), Medicine Shortage Reports Database. Official list. National shortages of reportable medicines, current and anticipated within six months; one row per product.